Abstract

H. Pylori infection is one of the most common infections worldwide. The aim of this study is to explore the current strategies in the diagnosis and treatment of H. pylori infection in Sulaimani city. A prospective study was the analytic method; this study involved 50 patients with H. pylori infection who were diagnosed in different health authorities in Sulaimani city. A questionnaire was designed to collect data about demographic features, risk factors, and clinical presentation, with special concern to those related to diagnosis and treatment; the patients were followed up to detect the response to management. Male to female ratio is equal to 1:1.6, and the most frequent age group was 30-39 years. The diagnosis was decided depending upon detection of serum anti- H.pylori antibodies (62%), H.pylori stool antigen (26%), urea breath test (8%), or only clinical features (4%). Monotherapy (46%), dual therapy (26%), or triple therapies (28%) were prescribed as first line of treatment. 28% of patients did not get cure from the infection and only 16% tried a second course without antibiotic sensitivity testing. Only 70% of patients were advised for flow up after treatment. The detection of serum anti-H. pylori antibodies are the main diagnostic technique, and monotherapy is the most commonly prescribed strategy for treatment of H. pylori infection. In Sulaimani city, when prescribing the treatment for H. pylori infection, it is highly recommended to follow the correct treatment protocols for management of H. pylori infections.

References

  • Adlekha S, Chadha T, Krishnan P, Sumangala B (2013) Prevalence of Helicobacter pylori infection among patients undergoing upper gastrointestinal endoscopy in a medical college hospital in kerala, India”, Annals of Medical and Health Science Research 3(4): 559-563.
  • Admas S (2016) Review of Biological Impacts of Genetically Engineered Crops and Neonicotinoid Treated Seed Use on Staten Island. The International Journal of Biotechnology, 5(4): 62-68.
  • Alvarado‐Esquivel C (2013) Seroepidemiology of Helicobacter pylori infection in pregnant women in rural Durango, Mexico. International Journal of Biomedical Science 9(4): 224-229.
  • Al-Windi A, Hussain A, Salih N (2013) Seroprevalence of anti-Helicobacter pylori antibodies in population of Sulaimani governorate/Kurdistan Region/Iraq. Journal of Zankoy Sulaimani- Part A. 15(3): 175-185.
  • Arkinson A, Gold D, Bulkow L, Wainwright R, et al. (2000). High prevalence of Helicobacter pylori in the Alaska native population and association with low serum ferritin levels in young adults. Clinical Diagnostic Laboratory Immunology. 7(6): 885-888. https://doi.org/10.1128/cdli.7.6.885-888.2000
  • Atherton J (2006) The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annual Review of Pathology 1(1): 63-96.
  • Brown L (2000) Helicobacter Pylori: Epidemiology and Routes of Transmission. Epidemiologic Reviews 22(2): 283-297.
  • Cardenas M, Prieto-Jimenez A, Mulla D, Rivera O, et al. (2000) Helicobacter pylori infection in children of Texas. Journal of Pediatric Gastroenterology and Nutrition 52(3): 326-332.
  • Chey W, Leontiadis G, Howden C, Moss S (2017) ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. The American Journal of Gastroenterology 112(2): 212-239.
  • De-Martel C, Parsonnet J (2006) Helicobacter pylori Infection and Gender: A Meta-Analysis of Population-Based Prevalence Surveys. Digestive Diseases and Sciences. 51(12): 2292-2301.
  • Den-Hollander J, Holster L, Den-Hoed M, Van-Deurzen F, et al. (2013) Ethnicity is a strong predictor for Helicobacter pylori infection in young women in a multi‐ethnic European city. Journal of Gastroenterology and Hepatology 28(11): 1705-1711. https://doi.org/10.1111/jgh.12315
  • Eusebi H, Zagari M, Bazzoli E (2014) Epidemiology of Helicobacter pylori Infection. Helicobacter 19(1): 1-5. https://doi.org/10.1111/hel.12165
  • Kusters J, Van-Vliet A, Kuipers E (2006) Pathogenesis of Helicobacter pylori infection Clinical Microbiology Reviews 19(3): 449-490. https://doi.org/10.1128/CMR.00054-05
  • Lane JA, Murray LJ, Harvey IM, et al. (2011) Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacology Therapy 33: 922-929. https://doi.org/10.1111/j.1365-2036.2011.04610.x
  • Lender N, Talley NJ, Enck P, Haag S, et al. (2014) Review article: Associations between Helicobacter pylori and obesity—An ecological study. Alimentary Pharmacology Therapy 40: 24-31. https://doi.org/10.1111/apt.12790
  • Li F, Chan L, Lu L, Shen J, et al. (2014) Cigarette smoking and gastrointestinal diseases: The causal relationship and underlying molecular mechanisms (Review). International Journal of Molecular Medicine 34(2): 372-380. https://doi.org/10.3892/ijmm.2014.1786
  • Malaty M, El-Kasabany A, Graham D, Miller C, et al. (2002) Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet. 359(9310): 931-935.
  • Mégraud H (2004) Pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53(4): 1374-1384. https://doi.org/10.1136/gut.2003.022111
  • Ogihara A, Kikuchi S, Hasegawa A, Kurosawa M, et al. (2000) Relationship between Helicobacter pylori infection and smoking and drinking habits. Journal of Gastroenterology and Hepatology 15(3): 271-276.
  • Ruggiero P (2010) Helicobacter Pylori and Inflammation. Current Pharmaceutical Design 16(38): 4225-4236.
  • Safavi M, Sabourian R, Foroumadi A (2016) Treatment of Helicobacter pylori infection: Current and future insights. World Journal of Clinical Cases 4(1): 5-19. https://doi.org/10.12998/wjcc.v4.i1.5
  • Vaira D, Gatta L, Ricci C, Miglioli M. (2002) Diagnosis of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 16(1): 16-23.
  • Wang Y, Kuo Y, Liu C, Wu M, et al (2018) Diagnosis of Helicobacter pylori infection: Current options and developments. World Journal of Gastroenterology. 21(40): 11221-11235. https://doi.org/10.3748/wjg.v21.i40.11221

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.